COVID19
Moneylife Digital Team 19 June 2021
Two months back when the relentless second wave of COVID started, we started seeing people drawn from different walks of life coming together and helping each other out of this adversity.

Read More

In order to ensure the cuts in GST rates of essential Covid-19 drugs and other medications is passed on to consumers, the National Pharmaceutical Pricing Authority has directed all pharma manufacturing and marketing companies to revise the maximum retail price (MRP) on drugs and formulations immediately taking into effect the reduced tax rate.

Read More

Moneylife Digital Team 16 June 2021
Refuting rumours spread by some social media posts about the use of new-born calf serum in Covaxin, the Union government on Wednesday clarified that the coronavirus (COVID) vaccine manufactured by Bharat Biotech Ltd, does not contain new-born calf serum.

Read More

There has been sharp decline in both new and active Covid-19 cases across India for the last few days, the Union Health Ministry said on Tuesday.

Read More

Innumerable RTI activists and users across the country have sought information since April 2020, regarding various issues related to the catastrophic COVID-19 pandemic that directly affects every citizen of this country

Read More

Moneylife Digital Team 11 June 2021
A few weeks back when the country was dealing with the gruesome second wave of the COVID-19 pandemic with hospitals running over-capacity along with massive shortage of health care facilities, medicines and oxygen, many corporates across India pitched in to help in COVID relief efforts.

Read More

The US Food and Drug administration has denied approval for emergency use of Covaxin, developed by Hyderabad-based Bharat Biotech, and has asked for additional data, biopharmaceutical Ocugen, the US partner of the Indian vaccine maker has said.

Read More

As economic activities have slowed down amid the second wave of Covid-19 and lockdowns across states, a Finance Ministry report has said that faster vaccine coverage and frontloading of fiscal measures announced in this year's budget would be the major factors in boosting the investment and consumption cycles and, in turn, reviving the economy.

Read More

Coronil, the so-called immunity booster kit manufactured by yoga guru Ramdevs Patanjali group in India, has landed in a controversy in Nepal after the Himalayan nations Department of Ayurveda and Alternative Medicine imposed a ban on its distribution.

Read More

From Tuesday onwards, Covid-19 vaccine doses provided free of cost by the Central government to states and the Union Territories (UTs) will be allocated based on criteria such as population, disease burden and the progress of vaccination.

Read More

The National Commission for Protection of Children's Rights (NCPCR) told the Supreme Court that as many as 3,621 children were orphaned, 274 were found abandoned and 26,176 lost either parent since April 1, 2020 and June 5, 2021, amid the ongoing Covid-19 pandemic.

Read More

Moneylife Digital Team 07 June 2021
Accepting main demand of opposition state governments and public health experts,

Read More

Moneylife Digital Team 07 June 2021
The second wave of coronavirus (COVID-19) has thrown cold water over the Indian economy that was beginning to warm up after the most severe contraction since Independence

Read More

Vaccines and mRNA-based technologies have rapidly emerged as promising new therapeutic modalities, but Indian companies are lagging behind in adopting these innovation platforms.

Read More

The on-tap liquidity window of contact-intensive sectors including travel and tourism, hotels, parlours and event organisers, announced by the Reserve Bank of India (RBI), will be operational from Monday.

Read More

Moneylife Digital Team 04 June 2021
It been more than two months since the country started grappling with the second wave of coronavirus (COVID) and when every institution was overwhelmed by the pressure of rising new cases.

Read More

In a major relief for patients suffering from mucormycosis (black fungus), the Maharashtra government on Friday announced a cap on the treatment rates charged by private hospitals.

Read More

In a significant ruling, the Bombay High Court has said that it would be the responsibility of the Centre in case any faulty ventilators supplied by a Gujarat company through the PM CARES Fund cause deaths of Covid-19 patients.

Read More

Pune-based Serum Institute of India (SII), which manufactures Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources.

Read More

Free Helpline
Legal Credit
Feedback